Some UK industries will feel the impact of Brexit more deeply than others. KPMG's sector experts explore the potential outcomes for your industry.
Chris Stirling, Global Chair of KPMG Life Sciences, argues that UK pharma should aspire to the Swiss position.
As the UK prepares to leave the EU, KPMG’s Giles Williams outlines which issues financial services should be focusing on now.
© 2017 KPMG LLP, a UK limited liability partnership, and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative, a Swiss entity. All rights reserved.